Powered by

-New Data From Immutep's Efti To Be Presented At ESMO

Aug 26, 2020 - ENP Newswire

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep' or 'the Company'), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, pleased to announce new data is scheduled to be presented in four poster presentations at the ESMO Virtual Congress 2020 which is being held from 19 to 21 September 2020, Central European Summer Time (CEST).

The new data will be presented from Immutep's phase II TACTI-002 and the investigator-initiated phase I cl...